Company History and Legal Base
Medix research group is a privately owned medical consulting and research company. It was established in 1991, with a network of clinical research partners and academic professionals in multiple therapeutic areas providing a solid base for coverage.
MEDIX has been involved by an international CRO Partnership to establish a solid and reliable clinical monitoring and consultancy hub base, first in Hungary and then by gradual expansion in other Central-EU countries (HU, SK, CZ, SL). The scope of operation has territorial coverage for all the three main regions also, including Balkan Peninsula (RO, MLD, BG, GR), the West- Balkan countries (HR, SR, MD, BiH), and is currently under development for the region to Israel, Russia and the CIS countries.
MEDIX services have expanded with the consultancy portfolio since 2000, providing medical writing supporting services for product registration, materials, and applications for national and DCP Marketing Authorization procedures.
MEDIX has been involved in managing projects in applied medical science, developing medical devices for diagnostic and rehabilitation purposes, and (non-clinical) drug research. National and EU research grants support the projects.
Our vision is to provide personalised services to establish rational solutions with quality when managing projects to support medical science, throughout the drug development process, via established relationships with academic and research professional partners.
The clients range from small to medium-sized pharmaceutical and biopharmaceutical companies, device companies, academic hospitals and university clinics. MEDIX has established partnerships with international or local CROs, providing regional coverage of services.
MEDIX regional clinical, operational and start-up team experiences: Phase-II/III – in multiple therapeutic areas Phase III b/IV and Non-Interventional trials – in multiple therapeutic areas Phase I/ Phase II/a and BE projects for specific therapeutic areas
Our local experience and clinical trials services cover the CEE and West-Balkan countries and are recently under development with ISR, RUS, UKR, and the CIS countries.